ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2022 Congress

Venous Thromboembolism » VTE Epidemiology

Theme Navigation

  • ISTH 2022 Congress
    • Venous Thromboembolism
      • VTE Epidemiology

Abstract Number: PB1322

A ten-year Australian experience of splanchnic vein thrombosis

J. Oktaviana1, B. Lui1, P. Ho2, H. Lim1

Abstract Number: VPB1344

ABO blood group and factor viii level as risk factors for idiopathic venous thromboembolism.

A. Diaz1, M. Vazquez2, M. Ordoñez2, F. Neria2, J. Cachá2, M. Gomez2

Abstract Number: VPB1342

Aetiological profile of inferior veina cava thrombosis

R. Ben Salah1, F. Mkaouar2, o. Frikha2, F. Frikha2, Z. bAHLOUL3

Abstract Number: VPB1345

Assessment Of Venous Thromboembolism Risk Factors In Hospitalized Patients At The University of Nigeria Teaching Hospital, Enugu Nigeria

E. EZIGBO1, T. Nwagha2, V. NWUZOR3

Abstract Number: OC 23.4

Association of inflammation and coagulation biomarkers with Cerebral Venous Thrombosis Clinical and Imaging characteristics: results from FPCCVT

P. Billoir1, V. SIGURET2, L. Drouet3, E. Masson Fron4, A. Bagan Triquenot5, i. Crassard6, V. Le Cam Duchez7

Abstract Number: PB1332

Cerebral venous thrombosis: clinical, radiological, biological and etiological characteristics of a French Prospective Cohort: Comparison with ISCVT cohort

A. Triquenot Bagan1, I. Crassard2, L. Drouet3, P. Morange4, V. Wolff5, G. Godenèche6, V. Le Cam Duchez7

Abstract Number: PB1337

Changing Pattern of Venous Thrombosis events in 2021 associated with COVID in a teaching hospital

H. Rowswell1, T. Nokes2

Abstract Number: PB1330

Characteristics and trends of venous thromboembolism – local experience

D. Kigitovica, V. Gibietis, E. Rusa, S. Strautmane, A. Zaicenko, K. Dzirnieks, J. Birzulis, A. Skride

Abstract Number: PB1325

Chronobiology of Acute Deep Vein Thrombosis: A 28 Year Study of Lower Extremity Duplex Ultrasounds

D. Houghton, D. Vlazny, R. Meverden, P. Daniels, M. Bartlett, G. Hesley, A. Lekah, A. Casanegra, W. Wysokinski

Abstract Number: PB1317

Clinical series of patients with non-bacterial thrombotic endocarditis not associated with cancer or lupus anticoagulant/antiphospholipid antibodies.

A. Casanegra1, P. Patrzalek2, D. Houghton1, R. Kurmann1, W. Kuczmik3, D. Hodge4, A. Azza5, K. Klarich1, W. Wysokinski1

Abstract Number: PB1336

Clustering of coagulation factors in acute venous thromboembolism identifies clusters of thromboinflammatory and endothelial activation markers as independent predictors of recurrence and mortality.

A. Pallares Robles1, V. ten Cate2, A. Schulz3, J. Prochaska2, T. Koeck4, S. Heitmeier5, R. Ewert6, M. Halank7, C. Espinola-Klein8, K. Lackner9, T. Münzel10, H. ten Cate11, A. ten Cate-Hoek12, S. Konstantinides13, P. Wild2

Abstract Number: OC 54.4

Development and validation of a clinical prediction model for 90-day venous thromboembolism risk following total hip and total knee arthroplasty

B. Nemeth1, M. Smeets2, A. Pedersen3, E. Kristiansen3, M. Whyte4, L. Roberts5, S. de Lusignan6, S. le Cessie7, S. Cannegieter2, R. Arya8

Abstract Number: PB1316

Differences in coagulation parameters associated with glucocorticoid treatment in patients with a first venous thrombosis: data from the MEGA study

E. Camilleri1, N. van Rein1, N. Biermasz2, O. Dekkers3, R. Feelders4, M. Huisman5, M. Kaya6, F. Klok7, O. Meijer8, A. Pereira8, F. Rosendaal9, F. Shokri10, B. van Vlijmen11, S. Cannegieter1

Abstract Number: PB1324

Evaluating routine data sources and efficient methods to determine the incidence of venous thromboembolism and major bleeding in unselected medical and surgical inpatients.

D. Horner1, S. Rex2, M. Bursnall2, K. de Wit3, S. Goodacre2, B. Hunt4

Abstract Number: PB1321

Focused on cerebral venous thrombosis

S. Herrero Martin1, J. Hernández Cristobal2, M. Mora Argumanez3

Abstract Number: VPB1346

Frequency and risk factors associated with thromboembolic events in a Sickle Cell Disease cohort

D. Werneck Rodrigues1, L. Fonseca2, S. Souza3, T. Espósito2, N. Magalhães3, A. Santos2, R. Almeida4, J. Almeida1, M. Thomaz1

Abstract Number: PB1333

Hand grip strength and risk of incident venous thromboembolism: The Tromsø Study

O. Leknessund1, V. Morelli2, B. Strand3, J. Hansen4, S. Brækkan4

Abstract Number: PB1327

Health-Related Quality of Life and physical capacity in patients with residual perfusion defects after pulmonary embolism

Ø. Jervan1, S. Parker2, J. Gleditsch3, D. Rashid3, W. Ghanima4

Abstract Number: VPB1347

Higher In-hospital Mortality of Cancer-Associated Pulmonary Embolism: Findings from the CURES Registry

J. Liu1, Z. Zhang2, P. Yang3, Z. Zhai2

Abstract Number: OC 34.5

Identification of risk factors for major bleeding during anticoagulation and recurrent venous thromboembolism after its discontinuation in patients with a first unprovoked venous thromboembolism.

C. Gabara1, Y. Yamashita2, J. Aibar1, C. Zamora3, J. Moisés1, C. FONT1, R. Valle4, A. Bura-Riviere5, L. Mazzolai6, A. Lorenzo7, A. Ballaz8, O. Madridano9, J. Suriñach10, J. Fernández-Reyes11, A. Villalobos12, P. Verhamme13, J. López-Sáez14, A. Gil-Díaz15, J. Vela16, M. Monreal17

  • 1
  • 2
  • 3
  • Next Page »

« View all themes from the ISTH 2022 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley